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Abstract  
 
Neurodevelopmental processes are widely believed to underlie schizophrenia. Analysis of 
brain texture from conventional magnetic resonance imaging (MRI) can detect disturbance in 
brain cytoarchitecture. We tested the hypothesis that patients with schizophrenia manifest 
quantitative differences in brain texture that, alongside discrete volumetric changes, may 
serve as an endophenotypic biomarker. Texture analysis (TA) of grey matter distribution and 
voxel-based morphometry (VBM) of regional brain volumes were applied to MRI scans of 27 
patients with schizophrenia and 24 controls. Texture parameters (uniformity and entropy) 
were also used as covariates in VBM analyses to test for correspondence with regional brain 
volume. Linear discriminant analysis tested if texture and volumetric data predicted 
diagnostic group membership (schizophrenia or control). We found that uniformity and 
entropy of grey matter differed significantly between individuals with schizophrenia and 
controls at the fine spatial scale (filter width below 2 mm). Within the schizophrenia group, 
these texture parameters correlated with volumes of the left hippocampus, right amygdala 
and cerebellum. The best predictor of diagnostic group membership was the combination of 
fine texture heterogeneity and left hippocampal size. This study highlights the presence of 
distributed grey-matter abnormalities in schizophrenia, and their relation to focal structural 
abnormality of the hippocampus. The conjunction of these features has potential as a 
neuroimaging endophenotype of schizophrenia. 
 
Keywords: Classifier, Endophenotype, Magnetic resonance imaging, Neurodevelopment, 
Psychosis 
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1. Introduction 
The diagnosis of schizophrenia typically signals a lifelong psychotic disorder with pervasive 
costs to patients, families and society (Gustavsson et al., 2010). The varied and often 
complex profile of schizophrenia, including the variable expression of positive and negative 
symptoms, cognitions and behaviours, continues to challenge scientific understanding 
toward prevention, diagnosis, and therapy. One research goal is the identification of 
objective biomarkers to indicate the risk, presence and progression of schizophrenia. 
Consequently, genetic endophenotypes have been sought in affected patients and at-risk 
families (Gottesman and Gould, 2003), and schizophrenia-related genes have been 
identified that influence the development of structural and functional microcircuitry within the 
brain (Harrison and Weinberger, 2005). Genes, while fundamental to vulnerability, are 
nevertheless difficult to link to the pathoetiological processes that ultimately determine onset 
of schizophrenia. Hence there is increasing effort to identify proximate imaging 
endophenotypes of schizophrenia for clinical utility (Meyer-Lindberg and Weinberger, 2006; 
Rasetti and Weinvberger, 2011) which can be combined with other objective markers and 
traits to give an extended endophenotype for schizophrenia (Prasad and Keshavan, 2008; 
Keshavan et al., 2011).  
 
In the present study, we tested the hypothesis that grey-matter heterogeneity (quantified 
from structural magnetic resonance imaging (MRI) of the brain and indicative of subtle 
distributed differences in cytoarchitectonic organisation) will distinguish the brains of people 
with and without schizophrenia, thereby representing a putative imaging endophenotype of 
schizophrenia. This hypothesis about brain texture is motivated by a proof-of-principle study 
that showed measures of grey-matter heterogeneity distinguished patients with 
schizophrenia from controls and moreover were sensitive to the patients’ genetic status 
(Ganeshan et al., 2010). Texture analysis (TA) of MR images lies within the domain of 
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morphological surface measurement and provides a higher order means of assessing 
differences in cortical complexity (Kassner and Thornhill, 2010). TA enables the 
quantification of the grey-level pattern on MRI, via pixel inter-relations and spectral 
properties of the images (Kassner and Thornhill, 2010). Advances in methodological 
approaches to brain-image analysis, such as automated algorithms and improved image 
processing (including segmentation procedures), have made TA more accessible and 
appealing as a research tool for neuropsychiatry (Kassner and Thornhill, 2010). TA has 
established utility when applied to neuropsychiatric disorders including epilepsy (de Oliviera 
et al., 2013), multiple sclerosis (Theocharkaris et al., 2009), attention deficit hyperactivity 
disorder (Chang et al., 2012) and Alzheimer disease (Zhang et al., 2012). Additionally, TA 
has revealed differences in foetal brains at term reflecting disordered interuterine growth 
(Sanz-Cortes et al., 2013). Recent studies indicate the potential for grey-matter texture 
measures to serve as candidate endophenotypes for schizophrenia (Kovalev et al., 2003; 
Ganeshan et al., 2010) and Asperger syndrome (Radulescu et al., 2013). 
 
Volumetric measures have been more widely relied upon in structural neuroimaging studies 
using MRI (e.g. with voxel-based morphometry, VBM). In schizophrenia, relative reductions 
in grey-matter volume are reliably reported both for whole brain, and broadly for specific 
regions. However, there also remains variability across studies in the observed magnitude 
and distribution of such local volume reductions (Shenton et al., 2001; Shepherd et al., 
2012). Some of the most replicated findings suggest grey-matter volume is reduced across 
large networks, differentially involving frontal, temporal, limbic, thalamic and striatal regions 
(Fornito et al., 2009; Honea et al., 2005). Regional grey-matter volume is influenced by 
interacting genetic and environmental factors (Wright et al., 2002; Cannon and Keller, 2006) 
expressed through cytoarchitectural differences (Hof et al., 2003; Schmitt et al., 2008). 
However, empirical experience to date suggests that volumetry on its own may be 
insufficient to generate useful endophenotypes in part because of the regional inconsistency 
of observed effects.  
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Cortical surface measures (including cortical thickness, cortical surface area and, indirectly, 
TA) are now generally regarded as a more proximate index of neurodevelopmental 
deviations in cytoarchitectural organization (Fischl and Dale, 2000; Mangin et al., 2010) and 
associated structural connectivity (White and Hilgetag, 2011). In patients with schizophrenia, 
when compared with healthy controls, prefrontal and temporal cortices show reductions in 
cortical thickness and surface area, with relative sparing of more posterior regions 
(Kuperberg et al., 2003; Rimol et al., 2010; Nesvag et al., 2011; Kubota et al., 2011). Cortical 
surface parameters, like volumetric measures, vary with age and medication history 
(Wiegand et al., 2004; Nesvag et al., 2011; Kubota et al., 2011). Nevertheless, studies 
indicate that cortical surface parameters are linked to neurodevelopmental processes that 
undergo only partial reshaping across the lifespan (Wienberger and McClure, 2002; Mangin 
et al., 2010). Surface parameters can be viewed as promising endophenotypes (Cannon et 
al., 2002; Goghari et al., 2007; Goldman et al., 2009; Qiu et al., 2010). Methods for 
characterizing cortical surface morphology, for example, by folding patterns, continue to 
emerge. These approaches, including TA, might more closely characterize the hidden 
architectural structure and subtle influence of antecedent neurodevelopmental events 
(Mangin et al., 2010)  
 
In the current study, we used TA to quantify grey-matter heterogeneity from MRI brain scans 
of patients with schizophrenia and healthy controls. We first tested for anticipated differences 
between the groups. We then tested for relationships between measures of whole brain 
textural heterogeneity and regional volumes (derived using VBM). Finally, we combined the 
texture parameters with VBM findings to create composite measures that were tested for 
their capacity to discriminate individuals with respect to their diagnosis status. 
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2. Methods 
 
2.1. Participants 
We analyzed the T1-weighted structural MRI brain scans of 51 individuals (27 with 
schizophrenia (SCZ) according to DSM-IV-TR (American Psychiatric Association, 2000), and 
24 controls). The majority of the individuals in this sample were males (SCZ: M/F=25/2; 
controls: M/F=23/1). Exclusion criteria were as follows: (a) antecedents for relevant medical 
and neurological diseases (i.e., brain trauma, psychoses of metabolic, infectious or vascular 
origin, epilepsy); (b) DSM-IV-TR criteria for substance abuse or dependence; (c) cognitive 
disorders (dementia, mental retardation, and learning disorders); and (d) contraindications to 
MRI scanning. All but two SCZ patients were treated with antipsychotics. The majority of the 
treated individuals received atypical antipsychotics (21/25). Participants’ premorbid IQ was 
assessed with a measure of crystallized intelligence, the National Adult Reading Test 
(NART) (Nelson and Willison, 1991). All participants gave written informed consent before 
enrolment, and the local Research Ethics Committee approved the study in accordance with 
the ethical standards of the Declaration of Helsinki (1964). The sample examined here was 
detailed in a previous study (O’Daly et al., 2007).  
 
2.2. Statistical analyses of demographic and global structural data 
The initial analysis comprised group comparisons regarding demographic and whole brain 
volumetric data. Age, IQ, global grey-matter volume, and total intracranial volume entered in 
analysis of variance (ANOVA) models as dependent variables; diagnostic status was 
introduced as fixed factor.  
 
2.3. Magnetic resonance imaging (MRI)  
All the participants were scanned with a GE Signa 1.5-T system (GE Medical Systems, 
Milwaukee, WI) at the Maudsley Hospital, London. Axial 3D T1-weighted images were 
acquired with a fast gradient-echo sequence under the following parameters: slice 
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thickness=1.5 mm, repetition time (TR) =8.7 ms, echo time (TE) =1.8 ms, matrix size=256 × 
192, field of view (FOV) =24 × 18 cm, in-plane resolution=0.94 × 0.94 mm, number of 
slices=124, flip angle=20○. The total scanning time was close to 8 min. 
 
2.4. Image pre-processing  
The structural images were processed for TA following a previously described protocol 
(Radulescu et al., 2013). Briefly, the T1 images were re-sliced to a 0.9 × 0.9 × 0.9 mm3 voxel 
dimension and segmented in six tissue classes (grey matter, white matter, cerebrospinal 
fluid, bone, soft tissue and air/background) by using the unified segmentation algorithm 
implemented in SPM8 (Wellcome Trust Centre for Neuroimaging, London, UK). Grey-matter 
images resulting from segmentation were normalized to a template (generated from all the 
participants) using a diffeomorphic registration algorithm (DARTEL) (Ashburner and Friston, 
2009) and modulated to preserve the voxel-wise information about the tissue volume, then 
smoothed with an 8-mm full width half-maximum (FWHM) Gaussian kernel. The ‘raw’ grey-
matter segmented images (re-converted to DICOM format) were used for texture parameters 
extraction (TA) and the modulated and smoothed grey-matter images were used for VBM.  
 
2.5. Texture analysis (TA) 
Heterogeneity within the whole-brain grey-matter images was assessed using published 
methods (Ganeshan et al., 2010; Radulescu et al., 2013) implemented in TexRAD® 
(TexRAD Ltd, www.texrad.co.uk, Somerset, UK), a proprietary research software algorithm 
developed to visualise and quantify textural properties of tissues from medical imaging 
scans, with texture quantified in terms of statistical and histogram characteristics. In the 
present study, we extracted grey-matter textural parameters from unfiltered and filtered 
whole brain volumes: Image filtration consisted of the application to multiple slices of whole 
brain data of a two-dimensional (2-D) Laplacian of Gaussian (LoG) filter, at three different 
frequency scales (feature width): fine (filter value=0.5, filter width ≈ 2 mm in diameter), 
medium (filter value=1.0, filter width ≈ 4 mm in diameter), coarse (filter value=1.5, filter width 
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≈ 6 mm in diameter). The texture parameter from unfiltered and filtered data captured the 
average intensity of the grey-level signal within a whole brain image (mean of grey level), the 
irregularity or complexity of the grey signal (entropy), the distribution of the grey level  
(uniformity), the average intensity and proportion of the positive grey-level signal pixel values 
within an image (mean of positive pixels, proportion of positive pixels), variation/dispersion 
that exists from the mean grey-level intensity (standard deviation), asymmetry of the 
distribution (skewness) and pointiness or peakedness of the distribution (kurtosis) 
(Ganeshan et al., 2008). We used a filtration-quantification approach where the initial image 
filtration highlighted subtle features (at the fine, medium and coarse scales) followed by the 
use of first order statistical and histogram characteristics. These filtration-quantification-
based texture parameters were subsequently entered into statistical analyses to characterise 
and compare neuroimaging data from patients with schizophrenia and controls (Ganeshan et 
al., 2008).  
 
2.6. Statistical analyses based on texture parameters  
The main statistical analyses of texture parameters were undertaken using the general linear 
model (ANCOVA) (Fig. 1). We first verified that the data conformed to assumptions for 
homogeneity of variance (Levene’s test) including homogeneity of the correlation slopes (by 
testing for interaction effect diagnosis × covariates (e.g., grey-matter global volume, age). 
Texture parameters were then used as dependent variables in models testing for differences 
between schizophrenia patients and controls. To understand the regional impact of the 
statistically significant TPs, we further introduced selected texture parameters as covariates 
in VBM analysis (see below and Fig. 1).  
 
2.7. Voxel-based morphometry (VBM)  
Normalized, smoothed grey-matter images were analyzed with SPM8 (Wellcome Trust 
Centre for Neuroimaging, London, UK) using general linear full-factorial models. Diagnosis 
was the between-subjects factor. We tested for relationships between texture parameters 
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and regional brain volume by entering them as covariates of interest within the analytic 
model, testing for both within-group effects of texture parameters on grey-matter regional 
volumes and interactions with diagnosis. We controlled for effects of age and global grey-
matter volume by inclusion as covariates of no interest. Within VBM analyses, we set a high 
threshold of voxel intensity (0.8) as a masking procedure. Statistical inference was based on 
voxel-by-voxel t-tests at the whole brain level. We report results that survived a stringent 
threshold of p<0.05 after correction for voxel-wise multiple comparisons (Family Wise Error; 
FWE). 
 
Regional grey-matter volumes for each participant were computed from the clusters where 
texture parameters showed significant within-group or interaction effects. We used these 
volumetric measures to explore further the relationship between grey-matter texture and 
volume in schizophrenia patients and controls when controlling for other demographic and 
neuropsychological characteristics. For example, we anticipated that texture parameters and 
regional grey-matter volumes would be sensitive to aging, and we verified this hypothesis by 
regressing age, texture parameters and their interaction on regional grey-matter volumes 
within each group. Similarly, we tested for related effects of illness duration, adjusted for 
patient age.  We were unable to quantify lifetime exposure to antipsychotic medication, and 
assumed that this variable is related to illness duration as all participants had been treated 
with medication.  
 
Finally, we used a stepwise linear discriminant analysis to test the hypothesis that a 
combination of grey-matter texture and regional volumes would usefully predict a diagnosis 
of schizophrenia. Before this analysis, we computed regression scores (one per participant) 
for multi-collinear predictors (fine filter texture parameters) using data reduction by principal 
component analysis. Subsequently, over three-quarters of the entire participant image data 
were selected randomly to generate the discriminant model, while the remaining data were 
used for validation. The stepwise linear discriminant analysis tests for, and retains in the 
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model, only the variables with the greatest discriminative value (using F-values by default, 
minimum F to enter=3.84, maximum F to remove=2.71). A cross-validation procedure 
(leave-one-out) was used in generative sample, for model creation, and the model was 
further validated in the remaining 30% of the sample. For all statistical analyses conducted 
outside the imaging space, we used SPSS 20.0 software (IBM® SPSS® Statistics 20.0). 
3. Results 
 
The group of patients with schizophrenia and control participants (Table 1) did not 
significantly differ with respect to age (F(1,49)=0.17, p=0.682), IQ (F(1,49)=2.9, p=0.095), global 
grey-matter volume (F(1,49)=1.39, p=0.243), or total intracranial volume (F(1,49)=1.01, 
p=0.319).  
 
3.1. Texture parameters 
There were significant between-groups differences in measures of grey-matter texture at the 
fine spatial scale (but not at other spatial scales). Specifically, the grey-matter of patients 
with schizophrenia was less uniform (more heterogeneous) than that of the controls, as 
indicated by higher values for entropy (F(1,49)=8.23, p=0.006, effect size η2=0.146) and 
mean positive pixels (F(1,49)=4.07, p=0.049, effect size η2=0.078). Conversely, the controls 
had higher values of uniformity (F(1,49)=9.92, p=0.003, effect size η2=0.171) compared with 
the schizophrenia group (Fig. 2). Parameters at other spatial frequency scales did not 
discriminate between the patient and control groups at threshold significance. 
 
3.1. Voxel-based morphometry  
We tested for regions where local grey-matter volume correlated with the fine texture 
parameters (extracted from whole brain data) identified above (fine entropy, mean positive 
pixels and uniformity). Effects were observed in brain structures already implicated in 
schizophrenia: Entropy was inversely correlated with the grey-matter volume of the right 
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amygdala (MNI: 26 -3 17; cluster size=158 voxels, Z score=3.58; Fig. 3). Mean of positive 
pixels inversely correlated with a region of left cerebellum (MNI: -29 -68 -19, K=224, Z 
score=3.47; Fig. 3). Uniformity showed a positive correlation with grey-matter volume of left 
hippocampus (MNI: -24 -15 -18, K=105, Z score=3.56; Fig. 3).  These TA correlations were 
significant in the schizophrenia group only, but not in controls (Fig. 3, correlation plots). 
Moreover, the examined texture parameters had no effect on any other grey-matter regional 
volumes in the control group.  
 
3.3. Texture parameters, age and illness-duration effects on regional volumes 
In controls, neither the age, nor the fine filtered uniformity nor the age-by-uniformity 
interaction predicted the volume of the identified left hippocampal cluster. In the 
schizophrenia group, however, age marginally predicted the volume in the left hippocampal 
cluster (partial correlation coefficient=0.347, p=0.048); uniformity, as noted above, did 
predict the volume of the left hippocampal cluster, explaining the greatest proportion of the 
variance (partial correlation coefficient=0.428, p=0.017). When the interaction term, 
uniformity × age was introduced in the model, the age effect became statistically non-
significant and only the uniformity effect remained significant. In addition, the interaction 
effect was not significant. Age marginally predicted the volume of the left hippocampal 
cluster (partial correlation coefficient=0.347, p=0.048, as did age-adjusted illness duration 
(partial correlation=0.358, p=0.039). 
 
3.4. Stepwise linear discriminant analysis  
Texture parameters at the fine spatial scale were correlated, as was expected (Pearson 
coefficient>0.8). We therefore used principal component analysis to derive composite 
measures for each individual of the three discriminatory texture parameters. High 
correlations were also observed between left hippocampus and right amygdala volumes, but 
these measures were not combined together. We applied stepwise linear discrimination 
analysis, a conservative approach that removes redundant variables from the model, to 
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identify which specific region could add to grey-matter texture to predict diagnostic group 
membership. This approach identified the combination of left hippocampal grey-matter 
volume and fine texture score as best classifying schizophrenia patients and controls 
(canonical correlation=0.489, Wilks’ Lambda=0.761, p=0.006). The classification accuracy 
for the group from which the model was derived was 70%; the cross-validation accuracy 
within these selected cases was 65%, and the classification accuracy in the remaining 
validation sample (independent group) was 72.7% (Table 2). 
 
4. Discussion 
 
4.1. Interpretation  
The current study brings further evidence in support of distributed cytoarchitectonic 
abnormalities in schizophrenia manifest through measures of grey-matter heterogeneity at a 
fine spatial scale across brain, and quantifiable from standard structural MRI brain scans. 
Moreover, we argue for a testable and useable imaging endophenotype of schizophrenia, 
derived from the simple combination of a measure of fine grey-matter homogeneity and 
hippocampal volume. The classification accuracy of this pairing of tangible (i.e., with face-
validity) features is compelling when compared with black-box or related classification 
approaches involving many more components (e.g., Yoon et al., 2006; Kawasaki et al., 
2006). For example, an alternative approach to classification using a support vector 
machine, applied to the same dataset, reached an equivalent classification accuracy (70.6%) 
when the left hippocampus was included alongside five other textural and volumetric 
features (authors’ unpublished observations).  In using the more straightforward linear 
discriminant analytic (LDA) approach, we also overcame risks of overfitting data from this 
relatively small sample. 
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Neuropathological studies of people with schizophrenia indicate the presence of 
cytoarchitectural abnormalities within cortical grey matter and particularly in hippocampus, 
typically reduced hippocampal volume (Tamminga et al., 2010). However, such findings are 
not always replicated (particularly if controls are family members) (Gothelf et al., 2000). 
Disarray of pyramidal neurons at the boundary of CA1-CA2 and disordered laminar 
architecture of the entorhinal cortex, i.e., misplaced and aberrantly clustered neurons, have 
also been reported in schizophrenia (Weinberger, 1999, Harrison, 2004). These findings too 
are controversial, due to variable replication. More consistent is the finding of reduced size of 
hippocampal neuronal cell bodies (Weinberger, 1999, Harrison, 2004). Nevertheless, a 
stronger proposition is that microscopic abnormalities are present at dendritic and synaptic 
levels within the hippocampal formation (Harrison, 2004).  Interestingly, these microstructural 
differences are accompanied by reduced molecular markers of neurogenesis (e.g., Reif et 
al., 2007).  Involvement of white matter (myelin) and oligodendrocytes in schizophrenia has 
been reported in the dorsolateral prefrontal cortex (Uranova et al., 2004), superior frontal 
gyrus (Hof et al., 2003) and visual cortex (Matthews et al., 2012), consistent with distributed 
neurodevelopmental perturbation (supported also by an absence of histopathological 
indicators of neurodegeneration and gliosis (Harrison, 2004)).  The observed depletion of 
prefrontal oligodendrocytes has been linked to quantitative neuroimaging abnormalities in 
white matter in schizophrenia brains (Hof et al., 2003). Importantly, more recent post-mortem 
stereological studies also demonstrate marked oligodendrocyte depletion within the posterior 
hippocampus (Schmitt et al., 2009), providing further evidence of the central role of the 
hippocampus to the pathophysiology of schizophrenia reinforced by our in vivo observations. 
 
The observed differences in fine textural parameters between schizophrenia patients and 
controls confirm and extend the findings of a previous smaller study of an independent 
dataset (Ganeshan et al., 2010). The additional discovery in schizophrenia of the association 
between whole-brain fine texture abnormalities and the size of medial temporal lobe regions 
has pathoaetiological implications: Abnormalities in grey-matter texture may represent the 
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consequence of neurodevelopmental processes including disturbed neural migration and 
differentiation (Radulescu et al., 2013). Regional correlation between whole brain texture 
abnormalities may thus reveal the historical focus and origin of (now distributed) 
perturbations in neural micro-circuitry underlying the progression of schizophrenia. The 
observed link between fine grey-matter abnormalities and hippocampal volume suggests 
abnormality within a discrete neurocognitive system. In this study, the fact that this 
combination also predicts diagnosis of schizophrenia implicates a unitary aetiological 
pathway. However, our result is based on a schizophrenia group that included patients with 
a history of hallucinations (O’Daly et al., 2007). This is relevant since recent neuroimaging 
studies, quantifying the volume and shape of hippocampal subfields, report inverse 
correlations between the presence of positive symptoms (i.e., hallucinations) and 
hippocampal CA2-3 volume (Kuhn et al., 2012), and between the severity of positive 
symptoms and deformation of the posterior CA1 (Zierhut et al., 2013). Hippocampal CA 
regions are encompassed within our volumetric findings. This is certainly not the first time 
that the link between neurodevelopmental insult to hippocampus and the pathoetiology of 
schizophrenia has been made (Arnold and Trojanowski, 1996; Weinberger, 1999; Harrison, 
2004). Our findings nevertheless contextualise focal hippocampal involvement within 
distributed cortical abnormalities. We also observed a weaker association between fine grey-
matter texture and cerebellar volume in schizophrenic patients. Association between grey-
matter heterogeneity and cerebellar volume has been observed in autism too (Radulescu et 
al., 2013) and therefore may be indexing a parallel neural system for which an aberrant 
neurodevelopmental trajectory is shared between schizophrenia and autism. Speculatively, 
the expression of social cognitive deficits and abnormal mental coordination (i.e., ‘cognitive 
dysmetria’; Andreasen and Pierson 2008) in both these two disorders may arise from a 
common genetic basis (Psychiatric Genomics Consortium, 2013). Our findings in this study 
also broadly converge with those of an earlier study, which used different MRI textural 
features to differentiate the scans of patients with schizophrenia from those of controls 
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(Kovalev et al., 2003). The latter study ascribed textural differences in part to sulcal widening 
of inferior brain regions, including the medial temporal lobe.  
 
 
Overall our data show whole brain indices of fine texture reflecting cytoarchitectural 
organization are linked to hippocampal volume. These data suggest that distributed 
networks interacting with the hippocampus are compromised in schizophrenia. Additional 
research methods to quantify local neural integrity and white matter cortical connections 
(e.g., high field MR spectroscopy of the hippocampus and diffusion tensor imaging) are 
warranted to characterize causality in the relationship between hippocampal neural integrity 
and grey-matter microstructural organisation.  Our focus on grey-matter TA was motivated by 
evidence from neuropathology and neuroimaging suggesting that this tissue compartment is 
most likely to encompass micro-structural anomalies in schizophrenia (e.g., Harrison, 2004). 
Moreover, this focus also allowed us to explore directly relationships with grey-matter volumetric 
measures from the same individuals, allowing us to equate the two measures.  In both cases, the 
accuracy and precision of grey/white matter segmentation is important. Nevertheless, it remains 
likely that abnormalities in myelination contribute to microstructural (hence textural) differences 
within grey matter across the brain (Matthews et al., 2012). As noted, additional neuroimaging 
approaches (e.g., diffusion-weighted imaging) may be better suited to address 
neurodevelopmental abnormalities in white-matter structure. However, these techniques have yet 
to enter conventional neuroimaging assessment of psychiatric patients.   
 
Within this study, we tested for effects of age, not least because age-related changes in 
grey-matter volume are reported across VBM studies (Groelsch et al., 2010; Lemaitre et al., 
2012). Overall, in controls, our findings mirror those of a larger dataset of a normal aging 
population, which described relative sparing of medial temporal lobe with respect to volume 
(and cortical surface parameters) (Lemaitre et al., 2012) . The weak effect of age observed 
in the schizophrenia patients is more difficult to interpret, not least because of the potential 
confound of medication in this relatively small sample. Further studies will be necessary to 
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clarify the relationship between regional volumes, texture parameters and age in 
schizophrenia. One interesting question is what exactly is the relationship between MRI-
derived fine grey-matter textural parameters and brain architecture? Insight comes from post 
mortem studies reporting correspondence between high-resolution MRI and histological 
sections from the same individuals, stained for grey matter (cytoarchitecture) and white 
matter (myeloarchitecture) (Osechinskiy and Kruggel, 2009; Annese, 2012). Of note, 
myeloarchitecture dominates cytoarchitecture in terms of relative influence on structural MR 
signal variability in humans (Eikhoff et al., 2005). These studies suggest that texture 
parameters might be linked to the organization of subjacent myeloarchitecture and 
cytoarchitecture. Differences in fine texture possibly reflect microstructural disorganization in 
schizophrenia that originates in differences in structural connectivity. Axonal tension forces 
determine cortical shape and morphology (cortical folding) at the time of synapse formation 
(Van Essen, 1997; Hilgetag and Barbas, 2006). Since cortical folding is under genetic control 
(Rogers et al., 2010), sensitive indices of morphology including texture parameters may 
usefully serve as endophenotypes encapsulating local structural connectivity abnormalities 
in schizophrenia. Our data, while indirect, suggest that parameters of grey-matter texture, in 
conjunction with associated hippocampal volumetric measures, offer accessible, 
understandable, and testable imaging endophenotypes in schizophrenia.  
 
4.2. Limitations  
This study is informative only in the context of gender quasi-homogeneity. Consequently, the 
results may not extend to the female population, especially since gender differences in 
schizophrenia have been widely demonstrated (Hafner, 2003). Arguably, a potential limitation is 
the fact that the group of schizophrenia patients comprised participants with a history of 
hallucinations (O’Daly et al., 2007). While the presence of hallucinations is representative of a 
typical clinical sample in schizophrenia, yet it is possible that correlations between grey-matter 
texture and regional volumes were specifically mediated by microstructural re-arrangements 
specific to perceptual aberrations. Our findings provide a proof-of-principle case for further 
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investigation into the use of brain-texture analyses to enrich inferences gained from conventional 
structural neuroimaging. These proposed studies will benefit from a prospective approach in 
larger patient populations powered to quantify influences including gender, medication and 
medical histories on textural and volumetric features  
 
We used a very stringent mask of voxel intensity for volumetric comparisons and correlation 
with the texture parameters. While this reliably minimized the risk of false-positives, we 
cannot exclude the possibility of an increased false-negative rate, previously associated with 
masking in VBM (Ridgway et al., 2009). Even if we were to conclusively demonstrate texture 
parameters as a robust endophenotype, we acknowledge the potential non-genetic and 
environmental influences on these measures (i.e., age, medication, history of substance 
abuse). Also, further clarification of the relationship between grey-matter heterogeneity and 
hippocampal morphology might be achieved by applying more sophisticated computational 
methods for the parcellation and morphological characterization of MRI brain scans (Zierhut 
et al., 2013).  
 
In conclusion, our study highlights the presence of abnormal fine brain texture in 
schizophrenia and shows this to be an accessible imaging signature that is potentially useful 
for creating an in vivo schizophrenia endophenotype, represented by a combination of 
cortical surface-based measurements (textural parameters) and regional grey-matter 
volumes, especially within the medial temporal lobe. 
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Figure legends: 
 
Fig. 1. Methodological flow chart showing the principal analyses after grey-matter texture 
parameters extraction. Abbreviations: DVs=dependent variables; GLM=general linear model; 
TPs=textural parameters; GM=grey-matter; VBM=voxel based morphometry; 
SCZ=schizophrenia. 
 
Fig. 2: Box plots (means and confidence intervals) of the fine textural parameters 
significantly different between patients with schizophrenia and controls. 
 
Fig. 3:  
Top panels: Effects of fine spatial scale texture parameters on grey-matter regional volumes. 
Statistical Parametric Maps are overlaid on an MRIcron (Rorden and Brett, 2000) template. 
Colour bars: T scores from the VBM analysis; ‘x, y, z’: MNI coordinates; R2=coefficient of 
multiple correlation/ explained variance. 
Bottom panels: Plots of correlation between fine texture parameters and grey-matter regional 
volumes in schizophrenia and controls. 
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Table 1: Demographic and structural data 
 
 Schizophrenia (n=27) 
Mean ± SDc 
Control group (n=24) 
Mean ± SDc 
Total (n=51) 
Mean ± SDc 
Age 
 
31.11±9.33  
(min=18; max=48) 
32.17±8.9 
(min=19; max=57) 
31.61±9.04 
(min=18; max=57) 
IQd 
 
107.19±7.59 
(min=94; max=124) 
110.54±6.33 
(min=94; max=123) 
108.76±7.16 
(min=94; max=124) 
Grey matter 
 
0.71±0.05 
(min=0.6; max=0.79) 
0.73±0.07 
(min=0.6; max=0.87) 
0.72±0.06 
(min=0.6; max=0.87) 
Total 
intracranial 
volumee 
 
1.54±0.1 
(min=1.3; max=1.72) 
1.58±0.14 
(min=1.26; max=1.87) 
1.56±0.12 
(min=1.26; max=1.87) 
Duration of 
illness 
6.07±6.03 
(min=1; max=23) 
- - 
a Schizophrenia; b control group; c SD=standard deviation; d intelligence quotient; ein litres. 
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Table 2: Classification resultsa 
Diagnosis Predicted group 
membership 
Total 
Control Schizophrenia 
Cases 
Selected 
(~70%) 
Original Count Control 15 5 20 
Schizophrenia 7 13 20 
% Control 75.0 25.0 100.0 
Schizophrenia 35.0 65.0 100.0 
Cross-
validated 
Count Control 13 7 20 
Schizophrenia 7 13 20 
% Control 65.0 35.0 100.0 
Schizophrenia 35.0 65.0 100.0 
Cases not 
selected 
Original Count Control 3 1 4 
Schizophrenia 2 5 7 
% Control 75.0 25.0 100.0 
Schizophrenia 28.6 71.4 100.0 
a Linear discriminant analysis 
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Highlights 
• Abnormal gray matter texture is observed in brain scans schizophrenic patients 
• Brain texture measures are sensitive to microstructural abnormalities  
• Fine textural heterogeneity predicts medial temporal lobe volumes in schizophrenia 
• Brain texture with hippocampal size can be used to classify scans by diagnosis  
• Our findings suggest an imaging endophenotype for schizophrenia 
 
